Debevoise & Plimpton LLP and the Center for Reproductive Rights (CRR) recently defeated Louisiana’s motion to dismiss a comprehensive substantive due process challenge to the state’s TRAP laws. Last year, Debevoise and the CRR filed a lawsuit against the state of Louisiana’s abortion clinic licensing law that has since forced all but three clinics in the state to close. Read more >

Debevoise & Plimpton LLP is advising The Carlyle Group on its strategic minority investment in DiscoverOrg, the leading global sales and marketing intelligence platform. Read more >

Debevoise & Plimpton LLP secured an important win at the New York Court of Appeals on behalf of client Andrew Kolchins in his compensation dispute with his former employer. Debevoise also represents Mr. Kolchins and the brokerage firm he founded, Titan Energy Markets, in a related lawsuit commenced by EvoMarkets attempting to enforce restrictive covenants. Read more >

Debevoise & Plimpton LLP is advising Ullico Inc. in the cross-border take private acquisition of Student Transportation Inc. (TSX:STB) (NASDAQ:STB) by a purchaser group sponsored by Ullico and Caisse de dépôt et placement du Québec (CDPQ). The transaction is expected to close by the end of the second quarter of 2018. Read more >

Debevoise & Plimpton LLP has advised Motor Fuel Group (“MFG”) in the financing and tax structuring of its £1.2 billion acquisition of MRH, the U.K.'s largest petrol station and convenience retail operator. Read more >

Debevoise & Plimpton LLP advised J.P. Morgan Asset Management on the $510 million acquisition and related financing of Groupon’s headquarters, located at 600 W. Chicago Avenue, Chicago, Illinois, in a joint venture with Sterling Bay. Read more >

Debevoise & Plimpton LLP has advised PJSC MegaFon (“MegaFon”) in its transaction with PJSC VimpelCom (VimpelCom”), a Russian subsidiary of VEON Ltd. (“VEON”), to discontinue their Euroset joint venture. Read more >

Debevoise & Plimpton LLP advised Ambac Financial Group, Inc. on its holistic restructuring transaction, including the successful conclusion of the rehabilitation of the Segregated Account of Ambac Assurance Corporation. Read more >

Debevoise & Plimpton LLP is advising Johnson & Johnson on a global co-development and commercialization agreement between Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Theravance Biopharma Ireland Limited, a subsidiary of Theravance Biopharma, Inc. Total consideration for the transaction is approximately $1 billion. Read more >

Debevoise & Plimpton LLP is advising Syncora Holdings Ltd. on a reinsurance transaction with Assured Guaranty Corp., pursuant to which Assured will reinsure approximately $13.5 billion of Syncora insured financial guarantee policies, representing approximately 91% of Syncora's outstanding insured exposures. The transaction is expected to close no later than the end of the second quarter of 2018. Read more >

Debevoise & Plimpton LLP secured a victory following almost nine years of litigation in the Celexa and Lexapro Marketing and Sales Practices multidistrict litigation (MDL). The United State District Court for the District of Massachusetts granted summary judgment in Allergan’s favor and dismissed all claims of the remaining plaintiffs. This avoids a jury trial that had been scheduled to begin March 12. Read more >